OrbiMed Capital GP VIII LLC, Director at Sionna Therapeutics, Inc. (SION), sold 66,712 shares at $44.55 ($3.0M) on 2025-12-24, disclosed to the SEC on 2025-12-29.
Scheduled sale ($3.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.55 | 33,356 | $1.5M | 50.0% |
| 2 | $44.55 | 33,356 | $1.5M | 50.0% |
| Total | $44.55 avg | 66,712 | $3.0M | 100% |
| Filing → |
| SION | BUY | 2025-02-10 | $9.9M | — | Filing → |